KELLY PAPESH: Open Payments
NPI 1386181782 · SHERIDAN, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,176 in 33 payments from 9 companies in 2025. Trend: 2023 $3,219 · 2024 $3,231 · 2025 $5,176
Consulting: $2,925Food & beverage: $2,115Speaker / faculty: $137
| Company | Payments | Amount |
|---|---|---|
| Tanabe Pharma America, Inc. | 5 | $3,097 |
| Abbott Laboratories | 5 | $533 |
| Amneal Pharmaceuticals LLC | 7 | $501 |
| ABBVIE INC. | 5 | $482 |
| Merz Pharmaceuticals, LLC | 5 | $293 |
| MDD US Operations, LLC | 1 | $137 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 1 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: INFINITY, CREXONT, VYALEV, INBRIJA, AUSTEDO XR, KESIMPTA.
Industry payments across WY — which companies pay providers there.
